NovaBridge Biosciences (NBP)

NovaBridge Biosciences Statistics

Total Valuation

NBP has a market cap or net worth of $403.52 million. The enterprise value is $178.52 million.

Market Cap	403.52M
Enterprise Value	178.52M

Important Dates

The next estimated earnings date is Thursday, April 2, 2026, after market close.

Earnings Date	Apr 2, 2026
Ex-Dividend Date	n/a

Share Statistics

NBP has 115.29 million shares outstanding. The number of shares has increased by 6.88% in one year.

Current Share Class	n/a
Shares Outstanding	115.29M
Shares Change (YoY)	+6.88%
Shares Change (QoQ)	+27.55%
Owned by Insiders (%)	6.75%
Owned by Institutions (%)	23.79%
Float	64.71M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.56
P/TBV Ratio	1.56
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 14.47, with a Debt / Equity ratio of 0.01.

Current Ratio	14.47
Quick Ratio	14.24
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	-101.41%
Return on Capital Employed (ROCE)	-13.29%
Weighted Average Cost of Capital (WACC)	13.34%
Revenue Per Employee	n/a
Profits Per Employee	-$822,688
Employee Count	32
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +288.50% in the last 52 weeks. The beta is 1.67, so NBP's price volatility has been higher than the market average.

Beta (5Y)	1.67
52-Week Price Change	+288.50%
50-Day Moving Average	3.65
200-Day Moving Average	3.57
Relative Strength Index (RSI)	52.03
Average Volume (20 Days)	607,817

Short Selling Information

The latest short interest is 5.48 million, so 4.75% of the outstanding shares have been sold short.

Short Interest	5.48M
Short Previous Month	5.27M
Short % of Shares Out	4.75%
Short % of Float	8.47%
Short Ratio (days to cover)	9.35

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-34.74M
Pretax Income	-26.33M
Net Income	-26.33M
EBITDA	-34.67M
EBIT	-34.74M
Earnings Per Share (EPS)	-$0.30

Balance Sheet

The company has $228.27 million in cash and $3.28 million in debt, with a net cash position of $225.00 million or $1.95 per share.

Cash & Cash Equivalents	228.27M
Total Debt	3.28M
Net Cash	225.00M
Net Cash Per Share	$1.95
Equity (Book Value)	258.92M
Book Value Per Share	2.25
Working Capital	216.68M

Cash Flow

In the last 12 months, operating cash flow was -$16.95 million and capital expenditures -$45,000, giving a free cash flow of -$17.00 million.

Operating Cash Flow	-16.95M
Capital Expenditures	-45,000
Free Cash Flow	-17.00M
FCF Per Share	-$0.15

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NBP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.88%
Shareholder Yield	-6.88%
Earnings Yield	-6.52%
FCF Yield	-4.21%

Analyst Forecast

The average price target for NBP is $9.00, which is 157.14% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$9.00
Price Target Difference	157.14%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1